{"id":519830,"date":"2021-07-29T08:04:10","date_gmt":"2021-07-29T12:04:10","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/kala-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-host-conference-call\/"},"modified":"2021-07-29T08:04:10","modified_gmt":"2021-07-29T12:04:10","slug":"kala-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-host-conference-call","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/kala-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-host-conference-call\/","title":{"rendered":"Kala Pharmaceuticals to Report Second Quarter 2021 Financial Results and Host Conference Call"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">WATERTOWN, Mass., July  29, 2021  (GLOBE NEWSWIRE) &#8212; Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today announced that it will report second quarter 2021 financial results on Thursday, August 5, 2021. Management will host a conference call and live audio webcast to discuss these results and provide a business update at 8:00 a.m. ET.<\/p>\n<p>The dial-in numbers to access the conference call are 866-300-4091 (domestic) or 703-736-7433 (international) using the conference ID 3852499. To access a live webcast and subsequent archived recording of the call, please visit \u201cEvents\u201d in the \u201cInvestors\u201d section on the Kala website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=jzi9_d2kr-7qzdr2xXwCeFCgyrr9SOn7CQ8G6wGEGBxOhE1xe1nuLLdV_HEGEubeendlTybxT4P4-f6ML2TBDA==\" rel=\"nofollow noopener\" target=\"_blank\">http:\/\/kalarx.com<\/a>\/.<\/p>\n<p align=\"justify\">\n        <strong>About Kala Pharmaceuticals, Inc.<\/strong>\n      <\/p>\n<p>Kala is a biopharmaceutical company focused on the discovery, development, and commercialization of innovative therapies for diseases of the eye. Kala has applied its AMPPLIFY<sup>\u00ae<\/sup> mucus-penetrating particle (MPP) Drug Delivery Technology to two ocular therapies, EYSUVIS<sup>\u00ae<\/sup> (loteprednol etabonate ophthalmic suspension) 0.25% for the short-term (up to two weeks) treatment of signs and symptoms of dry eye disease and INVELTYS<sup>\u00ae<\/sup> (loteprednol etabonate ophthalmic suspension) 1% for the treatment of post-operative inflammation and pain following ocular surgery. The Company also has a pipeline of pre-clinical development programs targeted to address unmet medical needs, including both front and back of the eye diseases. For more information on Kala, please visit www.kalarx.com.<\/p>\n<p>\n        <strong>Investor Contacts: <\/strong><br \/>\n        <br \/>Jill Steier<br \/>Jill.steier@kalarx.com<br \/>781-996-5252<\/p>\n<p>Hannah Deresiewicz<br \/>hannah.deresiewicz@sternir.com <br \/>212-362-1200\u00a0<\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4NzU2NCM0MzE3MDY0IzIwODkyODU=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/334c70d6-050c-4311-8036-7bb9826acf9b\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>WATERTOWN, Mass., July 29, 2021 (GLOBE NEWSWIRE) &#8212; Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today announced that it will report second quarter 2021 financial results on Thursday, August 5, 2021. Management will host a conference call and live audio webcast to discuss these results and provide a business update at 8:00 a.m. ET. The dial-in numbers to access the conference call are 866-300-4091 (domestic) or 703-736-7433 (international) using the conference ID 3852499. To access a live webcast and subsequent archived recording of the call, please visit \u201cEvents\u201d in the \u201cInvestors\u201d section on the Kala website at http:\/\/kalarx.com\/. About Kala Pharmaceuticals, Inc. Kala is a &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/kala-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-host-conference-call\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Kala Pharmaceuticals to Report Second Quarter 2021 Financial Results and Host Conference Call&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-519830","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Kala Pharmaceuticals to Report Second Quarter 2021 Financial Results and Host Conference Call - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/kala-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-host-conference-call\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Kala Pharmaceuticals to Report Second Quarter 2021 Financial Results and Host Conference Call - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"WATERTOWN, Mass., July 29, 2021 (GLOBE NEWSWIRE) &#8212; Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today announced that it will report second quarter 2021 financial results on Thursday, August 5, 2021. Management will host a conference call and live audio webcast to discuss these results and provide a business update at 8:00 a.m. ET. The dial-in numbers to access the conference call are 866-300-4091 (domestic) or 703-736-7433 (international) using the conference ID 3852499. To access a live webcast and subsequent archived recording of the call, please visit \u201cEvents\u201d in the \u201cInvestors\u201d section on the Kala website at http:\/\/kalarx.com\/. About Kala Pharmaceuticals, Inc. Kala is a &hellip; Continue reading &quot;Kala Pharmaceuticals to Report Second Quarter 2021 Financial Results and Host Conference Call&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/kala-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-host-conference-call\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-07-29T12:04:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4NzU2NCM0MzE3MDY0IzIwODkyODU=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kala-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-host-conference-call\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kala-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-host-conference-call\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Kala Pharmaceuticals to Report Second Quarter 2021 Financial Results and Host Conference Call\",\"datePublished\":\"2021-07-29T12:04:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kala-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-host-conference-call\\\/\"},\"wordCount\":252,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kala-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-host-conference-call\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI4NzU2NCM0MzE3MDY0IzIwODkyODU=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kala-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-host-conference-call\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kala-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-host-conference-call\\\/\",\"name\":\"Kala Pharmaceuticals to Report Second Quarter 2021 Financial Results and Host Conference Call - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kala-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-host-conference-call\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kala-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-host-conference-call\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI4NzU2NCM0MzE3MDY0IzIwODkyODU=\",\"datePublished\":\"2021-07-29T12:04:10+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kala-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-host-conference-call\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kala-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-host-conference-call\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kala-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-host-conference-call\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI4NzU2NCM0MzE3MDY0IzIwODkyODU=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI4NzU2NCM0MzE3MDY0IzIwODkyODU=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kala-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-host-conference-call\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Kala Pharmaceuticals to Report Second Quarter 2021 Financial Results and Host Conference Call\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Kala Pharmaceuticals to Report Second Quarter 2021 Financial Results and Host Conference Call - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/kala-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-host-conference-call\/","og_locale":"en_US","og_type":"article","og_title":"Kala Pharmaceuticals to Report Second Quarter 2021 Financial Results and Host Conference Call - Market Newsdesk","og_description":"WATERTOWN, Mass., July 29, 2021 (GLOBE NEWSWIRE) &#8212; Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today announced that it will report second quarter 2021 financial results on Thursday, August 5, 2021. Management will host a conference call and live audio webcast to discuss these results and provide a business update at 8:00 a.m. ET. The dial-in numbers to access the conference call are 866-300-4091 (domestic) or 703-736-7433 (international) using the conference ID 3852499. To access a live webcast and subsequent archived recording of the call, please visit \u201cEvents\u201d in the \u201cInvestors\u201d section on the Kala website at http:\/\/kalarx.com\/. About Kala Pharmaceuticals, Inc. Kala is a &hellip; Continue reading \"Kala Pharmaceuticals to Report Second Quarter 2021 Financial Results and Host Conference Call\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/kala-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-host-conference-call\/","og_site_name":"Market Newsdesk","article_published_time":"2021-07-29T12:04:10+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4NzU2NCM0MzE3MDY0IzIwODkyODU=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kala-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-host-conference-call\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kala-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-host-conference-call\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Kala Pharmaceuticals to Report Second Quarter 2021 Financial Results and Host Conference Call","datePublished":"2021-07-29T12:04:10+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kala-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-host-conference-call\/"},"wordCount":252,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kala-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-host-conference-call\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4NzU2NCM0MzE3MDY0IzIwODkyODU=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kala-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-host-conference-call\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/kala-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-host-conference-call\/","name":"Kala Pharmaceuticals to Report Second Quarter 2021 Financial Results and Host Conference Call - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kala-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-host-conference-call\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kala-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-host-conference-call\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4NzU2NCM0MzE3MDY0IzIwODkyODU=","datePublished":"2021-07-29T12:04:10+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kala-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-host-conference-call\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/kala-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-host-conference-call\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kala-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-host-conference-call\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4NzU2NCM0MzE3MDY0IzIwODkyODU=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4NzU2NCM0MzE3MDY0IzIwODkyODU="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kala-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-host-conference-call\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Kala Pharmaceuticals to Report Second Quarter 2021 Financial Results and Host Conference Call"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/519830","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=519830"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/519830\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=519830"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=519830"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=519830"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}